A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network , led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular assist device heart pump may also benefit from a single dose of millions of powerful cells injected directly ... (more)
http://www.medicalnewstoday.com/releases/269112.php
http://www.medicalnewstoday.com/releases/269112.php
No comments:
Post a Comment